Compositions and therapeutic methods for the treatment of complement-associated diseases
US10111885B2 · kind B2 · utility
1Cited by
102References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2016 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Mar 10, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention comprises methods of modulating the complement cascade in a mammal and for treating and/or preventing diseases and disorders associated with the complement pathway by administering a compound of Formula I or Formula II, such as, for example, 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.